These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9566549)

  • 1. Neutralizing antibody and perinatal transmission of human immunodeficiency virus type 1. New York City Perinatal HIV Transmission Collaborative Study Group.
    Hengel RL; Kennedy MS; Steketee RW; Thea DM; Abrams EJ; Lambert G; McDougal JS
    AIDS Res Hum Retroviruses; 1998 Apr; 14(6):475-81. PubMed ID: 9566549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of maternal autologous neutralizing antibody in selective perinatal transmission of human immunodeficiency virus type 1 escape variants.
    Dickover R; Garratty E; Yusim K; Miller C; Korber B; Bryson Y
    J Virol; 2006 Jul; 80(13):6525-33. PubMed ID: 16775339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Features of HIV-1 that could influence maternal-child transmission.
    Kliks SC; Wara DW; Landers DV; Levy JA
    JAMA; 1994 Aug; 272(6):467-74. PubMed ID: 8040983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syncytium-inhibiting and neutralizing activity in maternal sera fail to prevent vertical transmission of human immunodeficiency virus type 1.
    Bal AK; Miller G; Viscarello R; Andiman WA
    Pediatr Infect Dis J; 1996 Apr; 15(4):315-20. PubMed ID: 8866800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal humoral factors associated with perinatal human immunodeficiency virus type-1 transmission in a cohort from Kigali, Rwanda, 1988-1994.
    Tranchat C; Van de Perre P; Simonon-Sorel A; Karita E; Benchaïb M; Lepage P; Desgranges C; Boyer V; Trépo C
    J Infect; 1999 Nov; 39(3):213-20. PubMed ID: 10714798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of neutralizing and enhancing antibodies to human immunodeficiency virus type 1 primary isolates in plasma of individuals infected with env Genetic subtype B and E viruses in Thailand.
    Auewarakul P; Louisirirotchanakul S; Sutthent R; Taechowisan T; Kanoksinsombat C; Wasi C
    Viral Immunol; 1996; 9(3):175-85. PubMed ID: 8890476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perinatal transmission of HIV type 1: associations with maternal anti-HIV serological reactivity. Mothers and Infants Cohort Study and the HIV-1 Perinatal Serology Working Group.
    Goedert JJ; Dublin S
    AIDS Res Hum Retroviruses; 1994 Sep; 10(9):1125-34. PubMed ID: 7530026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals.
    Moog C; Fleury HJ; Pellegrin I; Kirn A; Aubertin AM
    J Virol; 1997 May; 71(5):3734-41. PubMed ID: 9094648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vertical transmission of human immunodeficiency virus type 1: autologous neutralizing antibody, virus load, and virus phenotype.
    Husson RN; Lan Y; Kojima E; Venzon D; Mitsuya H; McIntosh K
    J Pediatr; 1995 Jun; 126(6):865-71. PubMed ID: 7776085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A longitudinal assessment of autologous neutralizing antibodies in children perinatally infected with human immunodeficiency virus type 1.
    Geffin R; Hutto C; Andrew C; Scott GB
    Virology; 2003 Jun; 310(2):207-15. PubMed ID: 12781708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group.
    Shaffer N; Roongpisuthipong A; Siriwasin W; Chotpitayasunondh T; Chearskul S; Young NL; Parekh B; Mock PA; Bhadrakom C; Chinayon P; Kalish ML; Phillips SK; Granade TC; Subbarao S; Weniger BG; Mastro TD
    J Infect Dis; 1999 Mar; 179(3):590-9. PubMed ID: 9952365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad cross-neutralizing activity in serum is associated with slow progression and low risk of transmission in primate lentivirus infections.
    Fenyö EM; Putkonen P
    Immunol Lett; 1996 Jun; 51(1-2):95-9. PubMed ID: 8811351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association between anti-V3 loop antibodies and perinatal transmission of HIV-1 in Kampala, Uganda.
    Epstein H; Guay L; Hom D; Mmiro F; Ndugwa C; Marum L; Olness K; Piwowar E; Kataaha P; Baenziger J
    Pediatr AIDS HIV Infect; 1994 Dec; 5(6):350-6. PubMed ID: 11361376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.
    Mofenson LM; Lambert JS; Stiehm ER; Bethel J; Meyer WA; Whitehouse J; Moye J; Reichelderfer P; Harris DR; Fowler MG; Mathieson BJ; Nemo GJ
    N Engl J Med; 1999 Aug; 341(6):385-93. PubMed ID: 10432323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York City Perinatal HIV Transmission Collaborative Study Group.
    Abrams EJ; Matheson PB; Thomas PA; Thea DM; Krasinski K; Lambert G; Shaffer N; Bamji M; Hutson D; Grimm K
    Pediatrics; 1995 Sep; 96(3 Pt 1):451-8. PubMed ID: 7651777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal Neutralization-Resistant Virus Variants Do Not Predict Infant HIV Infection Risk.
    Milligan C; Omenda MM; Chohan V; Odem-Davis K; Richardson BA; Nduati R; Overbaugh J
    mBio; 2016 Feb; 7(1):e02221-15. PubMed ID: 26838723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vertical HIV-1 Transmission in the Setting of Maternal Broad and Potent Antibody Responses.
    Tu JJ; Kumar A; Giorgi EE; Eudailey J; LaBranche CC; Martinez DR; Fouda GG; Moreau Y; Thomas A; Montefiori D; Gao F; Sagar M; Permar SR
    J Virol; 2022 Jun; 96(11):e0023122. PubMed ID: 35536018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates.
    Scarlatti G; Albert J; Rossi P; Hodara V; Biraghi P; Muggiasca L; Fenyö EM
    J Infect Dis; 1993 Jul; 168(1):207-10. PubMed ID: 8515110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers. New York City Collaborative Study of Maternal HIV Transmission and Montefiore Medical Center HIV Perinatal Transmission Study Group.
    Rogers MF; Ou CY; Rayfield M; Thomas PA; Schoenbaum EE; Abrams E; Krasinski K; Selwyn PA; Moore J; Kaul A
    N Engl J Med; 1989 Jun; 320(25):1649-54. PubMed ID: 2725615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of autologous neutralizing antibody to human immunodeficiency virus type 1 (HIV-1) and macrophage tropism are associated with mother-to-infant transmission.
    Lathey JL; Tsou J; Brinker K; Hsia K; Meyer WA; Spector SA
    J Infect Dis; 1999 Aug; 180(2):344-50. PubMed ID: 10395848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.